(a) The commission shall publish on the commission’s Internet website any decisions on preferred drug list placement, including:
(1) a list of drugs reviewed and the commission’s decision for or against placement on a preferred drug list of each reviewed drug;
(2) for each recommendation, whether a supplemental rebate agreement or a program benefit agreement was reached under Subchapter C; and
(3) the rationale for any departure from a board recommendation under § 549.0309.
(b) The commission shall:
(1) provide for the distribution of current copies of the preferred drug lists adopted under this subchapter by posting the lists on the Internet; and
(2) mail copies of the lists to a health care provider on the provider’s request.

Text of section effective on April 01, 2025